FDA OKs Diabetes Drug for Type 2 Heart Failure Risk
The FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Health | Heart | Heart Disease | Heart Failure